Germany· DE-A57-7ae39a5f072ca94d
Moxifloxacin Ratiopharm
A moxifloxacin product containing moxifloxacin, registered in Germany by Ratiopharm Gmbh. The same ATC class is registered in 16 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Moxifloxacin is registered in 16 of 19 countries.
Countries holding a registration under ATC J01MA14 (moxifloxacin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 9 of them publish a price we can compare per daily dose
Moxifloxacin · ATC J01MA14
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of moxifloxacin costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $1.34 in United States to $6.89 in Switzerland — a ×5.2 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Moxifloxacin · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$6.89
- IT Italy$1.99
- US United States$1.34 (acquisition cost)
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Moxifloxacin
- Manufacturer
- Ratiopharm Gmbh
- Country
- Germany (DE)
- ATC code
- J01MA14
- ATC class
- Moxifloxacin
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
531 interactions on record for moxifloxacin.
Graded by severity as the source publishes them — 175 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Moxifloxacin · interactions on record
531 records
- 175 severe
- 140 moderate
- 49 minor
- 92 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
75 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Moxifloxacin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMoxifloxacinSolaris Pharma Corporation
- SpainABIMOX 5 MG/ML COLIRIO EN SOLUCIONTiedra Farmaceutica S.L.
- United KingdomAvelox 400mg tabletsSigma Pharmaceuticals Plc
- PolandFlomixaFarmak International Sp. z o.o.
- CzechiaAVELOXBayer AG, Leverkusen
- FinlandActiraBayer HealthCare AG
- SwitzerlandAvalox
- BelgiumAvelox 400 mgBayer
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Avelox, Moxifloxacin 1a Pharma
- Belgium · Avelox, Kanavig
- Bulgaria · Cimocinox, Moxifloxacin Kabi
- Cyprus · Avelox, Erelan
- Czechia · Avelox, Moxifloxacin Brown & Burk
- Denmark · Moxifloxacin Accord, Moxifloxacin Fresenius Kabi
- Estonia · Avelox, Floxelan
- Spain · Abimox, Actira
- Finland · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
- France · Izilox, Moxifloxacine Arrow
- United Kingdom (Northern Ireland) · Avelox, Moxidox
- Greece · Avelox, Mikrobiel
- Croatia · Melvedok, Moksacin 5 Mg/Ml Kapi
- Hungary · Moxibiot, Moxifloxacin Anfarm
- Ireland · Moxifloxacin
- Iceland · Vigamox
- Italy · Avalox, Moxidrop
- Lithuania · Avelox, Ekara
- Luxembourg · Avelox, Kanavig
- Latvia · Avelox, Ekara
- Malta · Erelan, Moxifloxacin Anfarm
- Netherlands · Erelan, Moxifloxacin Hydrochloride Aurobindo
- Norway · Xinaflox
- Poland · Flomixa, Floxamic Neo
- Portugal · Avelox, Bluesar
- Romania · Avelox, Kimoks
- Sweden · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
- Slovenia · Kimoks, Moksifloksacin Kabi
- Slovakia · Avelox, Moloxin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ded9bd7c-459e-496b-9f0b-869b8c0a9368 GET /v1/drugs/ded9bd7c-459e-496b-9f0b-869b8c0a9368?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Moxifloxacin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about moxifloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.